SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-213107
Filing Date
2013-05-10
Accepted
2013-05-10 11:58:13
Documents
13
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d515969d10q.htm 10-Q 361950
2 EX-10.1 d515969dex101.htm EX-10.1 64514
3 EX-31.1 d515969dex311.htm EX-31.1 10324
4 EX-31.2 d515969dex312.htm EX-31.2 10328
5 EX-32.1 d515969dex321.htm EX-32.1 5064
6 EX-32.2 d515969dex322.htm EX-32.2 5068
13 GRAPHIC g515969ex10_1pg11.jpg GRAPHIC 6966
  Complete submission text file 0001193125-13-213107.txt   3100433

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT galt-20130331.xml EX-101.INS 298799
8 XBRL TAXONOMY EXTENSION SCHEMA galt-20130331.xsd EX-101.SCH 38720
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20130331_cal.xml EX-101.CAL 37835
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20130331_def.xml EX-101.DEF 212451
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20130331_lab.xml EX-101.LAB 300467
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20130331_pre.xml EX-101.PRE 250683
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 13831935
SIC: 2834 Pharmaceutical Preparations